BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide derived from a larger protein found in human gastric juice. The sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val has been studied extensively in preclinical models.
Mechanism of Action
BPC-157’s mechanisms are multifaceted and not fully characterized. Research suggests involvement of the nitric oxide (NO) system, the dopaminergic system, and the FAK-paxillin pathway. It appears to promote angiogenesis and modulate growth factor expression including VEGF, EGF, and FGF.
Stability
Unusually for a peptide of this size, BPC-157 demonstrates stability in human gastric juice conditions. This resistance to acid hydrolysis is attributed to the proline-rich sequence in positions 3โ5, which creates a rigid turn structure resistant to common endopeptidases.
Research Areas
Preclinical studies have examined BPC-157 in models of soft tissue injury, tendon repair, intestinal damage, and vascular function. The peptide has been administered through multiple routes in research settings including subcutaneous, intraperitoneal, and oral.